Share on facebook
Share on pinterest
Share on twitter
Share on email
Share on whatsapp

Avidekel Cannabis extracts and cannabidiol are as efficient as Copaxone in suppressing EAE in SJL/J mice

Inflammopharmacology 2018

Ruth Gallily1, Zhannah Yekhtin1

1The Lautenberg Center for General and Tumor Immunology, The Hadassah Medical School, The Hebrew University of Jerusalem, Jerusalem, Israel

Multiple sclerosis is an autoimmune disease that affects the central nervous system. The disease can be treated with immunosuppressive drugs that alleviate the symptoms and retard disease aggravation. An example of such a drug is Copaxone, an immunosuppressive medication that is used to alleviate the symptoms of multiple sclerosis. Recently, it has been shown that the cannabidiol component in the cannabis plant has a positive effect on the model of multiple sclerosis in animals, an acute, inflammatory disease that attacks the myelin sheath. The aim of this study, conducted in collaboration with the Hebrew University, was to compare the efficacy of purified CBD, extracts of CBD-rich Avidekel, and Copaxone.

STUDY POPULATION: Lab mice.

STUDY PRODUCT: Avidekel.

RESULTS:

  • Avidekel may be useful in the treatment of multiple sclerosis symptoms.
  • Avidekel strain extracts and cannabidiol are as efficient as COPAXONE® in immunosuppression in-vivo laboratory experiment examined the effect of multiple sclerosis symptoms in mice.
  • Both CBD and Avidekel extracts efficiently inhibited the clinical symptoms appearing during all the study phases.

FULL STUDY

Have you liked our facebook page?

Common Questions

Ordering Tikun Olam Products

Proudly leading the revolution for modern Cannabis treatment

Related Topics

Medical cannabis for inflammatory bowel disease: real-life experience of mode of consumption and assessment of side-effects. Eur J Gastroenterol Hepatol 2019 Timna Naftali 1 2,

Brief Report: Cannabidiol-Rich Cannabis in Children with Autism Spectrum Disorder and Severe Behavioral Problems—A Retrospective Feasibility Study J Autism Dev Disord, 2018 Adi Aran1 ·

Oral Cannabidiol Use in Children With Autism Spectrum Disorder to Treat Related Symptoms and Co-morbidities Frontiers in Pharmacology, 2019 Dana Barchel1, Orit Stolar2, Tal De-Haan1,

whatsapp